Followers | 247 |
Posts | 1365 |
Boards Moderated | 0 |
Alias Born | 11/22/2013 |
Tuesday, January 20, 2015 9:04:10 AM
A) Getting the patents and
B) Writing them in such a manner to not allow the competition to 'vary' the process and/or product in order to skirt the claim
...would make $STEV golden here.
They used an IP attorney, so fingers crossed. I do know big Pharma has lost of lawyers and creative patent processes as well!
I personally see the CBD/Medicine hybrids as a long term play who's best value for $STEV lies in a partnership or IP claims.
An additional full patent must follow the provisional within 12 months, be approved, and then as stated above, suitably apply to any copycats. It'll be a little bit IMO.
I'm leery of a partnership soon, as these companies may likely wait for the same, and to see if they could skirt the patent.
Conversely, maybe there is behinds the scenes talk with a Chinese Pharma company. This is where $STEV has it's ties.
I just want the hemp/stevia harvest info. This stuff is (IMO) a ways into the future and not driving revs today. I'm honestly not here for 2017, and I'm ticked it's 131 days now under a .10 here.
TM
FEATURED DBG Pays Off $1.3 Million in Convertible Notes, which Retires All of the Company's Convertible Notes • Nov 7, 2024 2:16 PM
SANUWAVE Announces Record Quarterly Revenues: Q3 FY2024 Financial Results • SNWV • Nov 8, 2024 7:07 AM
SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service • SMX • Nov 7, 2024 8:48 AM
Rainmaker Worldwide Inc. (OTC: RAKR) Announces Successful Implementation of 1.6 Million Liter Per Day Wastewater Treatment Project in Iraq • RAKR • Nov 7, 2024 8:30 AM
SBC Medical Group Holdings and MEDIROM Healthcare Technologies Announce Business Alliance • SBC • Nov 7, 2024 7:00 AM
VAYK Confirms Insider Buying at Open Market • VAYK • Nov 5, 2024 10:40 AM